4.5 Article

Epigenetic axis of SNHG19/miR-137/TNFAIP1 modulates amyloid beta peptide 25-35-induced SH-SY5Y cytotoxicity

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Geriatrics & Gerontology

Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p

Jingjing Zhang et al.

Summary: This study explored the regulatory effects of MAGI2-AS3 and miR-374b-5p on A beta-induced neurotoxicity and neuroinflammation in Alzheimer's disease. The findings suggest that the MAGI2-AS3/miR-374b-5p axis may serve as potential biomarkers and therapeutic targets for AD, as it can attenuate neuronal injury and inflammation. The expression levels of MAGI2-AS3 and miR-374b-5p were negatively correlated in AD patients and correlated with disease severity, highlighting their potential importance in AD pathogenesis.

EXPERIMENTAL GERONTOLOGY (2021)

Article Biochemistry & Molecular Biology

A 6-lncRNA signature predicts prognosis of diffuse large B-cell lymphoma

Hongyu Gao et al.

Summary: The study established a signature for DLBCL prognosis prediction based on lncRNAs, showing lower overall survival in high-risk group. A nomogram combining risk score and clinical characters was established for better predictive accuracy than individual factors. Weighted gene co-expression network analysis revealed potential regulatory roles of lncRNAs in immune response, metabolism, and signal transduction to impact prognosis.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2021)

Article Neurosciences

LncRNA BACE1-AS Promotes Autophagy-Mediated Neuronal Damage Through The miR-214-3p/ATG5 Signalling Axis In Alzheimer's Disease

Yuan Zhou et al.

Summary: Alzheimer's disease (AD) is characterized by progressive memory loss and cognitive dysfunction, with long non-coding RNAs (lncRNAs) showing promise as biomarkers and therapeutic targets. The study found that silencing of lncRNA BACE1-AS alleviated neuronal injury by regulating autophagy through the miR-214-3p/ATG5 signaling axis in AD. These findings suggest a potential therapeutic target for AD treatment.

NEUROSCIENCE (2021)

Article Oncology

被撤回的出版物: LncRNA SNHG19 Promotes the Development of Non-Small Cell Lung Cancer via Mediating miR-137/E2F7 Axis (Retracted article. See vol. 11, 2021)

Guang-Yin Zhao et al.

Summary: This study revealed that SNHG19 was upregulated in NSCLC tissues, patients plasma, and cell lines, and it promoted tumor progression via the miR-137/E2F7 axis. This provides new insights and potential targets for the diagnosis and treatment of NSCLC.

FRONTIERS IN ONCOLOGY (2021)

Article Clinical Neurology

Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060)

Kumar B. Rajan et al.

Summary: This study estimated the prevalence of clinical Alzheimer's disease in 2020 and projected future increases, finding a more significant growth among Hispanics and Blacks.

ALZHEIMERS & DEMENTIA (2021)

Article Biochemistry & Molecular Biology

TNFAIP1 Is Upregulated in APP/PS1 Mice and Promotes Apoptosis in SH-SY5Y Cells by Binding to RhoB

Ye Xiao et al.

Summary: This study reveals that TNFAIP1 is overexpressed in the neurons of AD mice, and it plays a role in Aβ-induced apoptosis through the RhoB signaling pathway, leading to increased ROS production and decreased mitochondrial membrane potential.

JOURNAL OF MOLECULAR NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

Knockdown of lncRNA SNHG1 attenuated Aβ25-35 -inudced neuronal injury via regulating KREMEN1 by acting as a ceRNA of miR-137 in neuronal cells

Hui Wang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Article Neurosciences

Tau Kinetics in Neurons and the Human Central Nervous System

Chihiro Sato et al.

NEURON (2018)

Article Neurosciences

Alzheimer's Disease and the Amyloid-β Peptide

M. Paul Murphy et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Article Biochemistry & Molecular Biology

miR-137 attenuates Aβ-induced neurotoxicity through inactivation of NF-κB pathway by targeting TNFAIP1 in Neuro2a cells

Dan He et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Review Clinical Neurology

Impact of multiple pathologies on the threshold for clinically overt dementia

Alifiya Kapasi et al.

ACTA NEUROPATHOLOGICA (2017)

Article Biology

History, Discovery, and Classification of lncRNAs

Julien Jarroux et al.

LONG NON CODING RNA BIOLOGY (2017)

Article Biochemistry & Molecular Biology

DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts

Maria D. Paraskevopoulou et al.

NUCLEIC ACIDS RESEARCH (2016)

Review Toxicology

MicroRNA epigenetic signatures in human disease

Klara Piletic et al.

ARCHIVES OF TOXICOLOGY (2016)

Review Geriatrics & Gerontology

Long noncoding RNAs and Alzheimer's disease

Qiong Luo et al.

CLINICAL INTERVENTIONS IN AGING (2016)

Article Geriatrics & Gerontology

Identification of Alzheimer's disease-associated long noncoding RNAs

Xiaolin Zhou et al.

NEUROBIOLOGY OF AGING (2015)

Review Medicine, General & Internal

Amyloid-Beta: A Crucial Factor in Alzheimer's Disease

Saeed Sadigh-Eteghad et al.

MEDICAL PRINCIPLES AND PRACTICE (2015)

Article Multidisciplinary Sciences

Systematic Transcriptome Wide Analysis of lncRNA-miRNA Interactions

Saakshi Jalali et al.

PLOS ONE (2013)

Review Genetics & Heredity

Non-coding RNAs in human disease

Manel Esteller

NATURE REVIEWS GENETICS (2011)

Review Multidisciplinary Sciences

A century of Alzheimer's disease

Michel Goedert et al.

SCIENCE (2006)